Importation of plasma and use of apheresis platelets as risk reduction measures for variant Creutzfeldt-Jakob Disease – Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) Paediatric Components Working Group (PCWG)

Report from SaBTO’s Paediatric Components Working Group looking at whether scientific evidence supports updating specific vCJD risk reduction measures.  This document reports on the findings of the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) Paediatric Components Working

Emicizumab as prophylaxis in people with severe congenital haemophilia A without factor VIII inhibitors (all ages) – NHS England

NHS England will commission emicizumab as prophylaxis in people with severe congenital haemophilia A without factor VIII inhibitors in accordance with the criteria outlined in this policy.

HSC (2007) 001: Better blood transfusion: safe and appropriate use of blood – Department of Health

This circular replaces HSC 2002/009 building on previous Better Blood Transfusion initiatives. Improving transfusion safety and effectiveness; avoiding unnecessary use of blood components,Platelets and Fresh Frozen Plasma; focussing on the use of anti-D in Obstetrics; and patient and public involvement.

SCT screening data flows to the National Congenital Anomaly and Rare Disease Registration Service – Public Health England

Flowchart showing the sickle cell and thalassaemia (SCT) screening newborn outcomes project pathway. The document includes actions for: babies with a newborn blood spot screen positive result clinical presentation of an affected child or infant

Haemoglobinopathy Coordinating Centres Engagement Report – NHS England

Engagement report on the service specification for specialist haemoglobinopathy co-ordinating centres to support the provision of specialist and non-specialist haemoglobinopathy services to adults and children and to provide expert opinion and management for complex patients.

Specialist Haemoglobinopathy Teams Engagement Report – NHS England

Service specification engagement report for  haemoglobinopathy coordinating centres to support the provision of specialist and non-specialist haemoglobinopathy services to adults and children and to provide expert opinion and management for complex patients.

Haemoglobinopathy Coordinating Centres Service Specification – NHS England

Service specification for  haemoglobinopathy coordinating centres to support the provision of specialist and non-specialist haemoglobinopathy services to adults and children and to provide expert opinion and management for complex patients.

Specialist Haemoglobinopathy Teams Service Specification – NHS England

Service specification for specialist haemoglobinopathy teams to support the provision of specialist and non-specialist haemoglobinopathy services to adults and children and to provide expert opinion and management for complex patients.

Information for patients on the Infected Blood Inquiry – Public Health England

The Infected Blood Inquiry (IBI) is a public inquiry which will examine the circumstances in which patients treated by the NHS in the 1970s and 1980s received infected blood and/or blood products; the impact on their families; how the authorities

Information for GPs on the Infected Blood Inquiry – Public Health England

The Infected Blood Inquiry (IBI) is a public inquiry which will examine the circumstances in which patients treated by the NHS in the 1970s and 1980s received infected blood and/or blood products; the impact on their families; how the authorities

Donor Selection Criteria Report (2017) Version 2 – Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO)

This report from The Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) recommends reducing a number of ‘deferral periods’, the time between engaging in certain behaviours and donating blood, tissue or cells. The report explores issues including:

Clinical Commissioning Policy: Susoctocog alfa for treating bleeding episodes in people with acquired haemophilia A (all ages) – NHS England

This policy document outlines the arrangements for funding of treatment for bleeding episodes in people with acquired haemophilia A.